Newsroom

Institute for Data Science in Oncology announces new focus-area lead for advancing data science to reduce public cancer burden

January 30, 2026

The Institute for Data Science in Oncology (IDSO) at The University of Texas MD Anderson Cancer Center today announced the appointment of Iakovos Toumazis, Ph.D., to lead its focused efforts in advancing decision analytics for health.

The goal of this new IDSO focus area is to develop, rigorously validate and implement advanced data‑driven analytics frameworks that support optimal decision‑making to enhance patient outcomes, to...

Three New Cancer Projects Receive Funding in Joint Collaboration Between Oden Institute, MD Anderson's IDSO and TACC

BY Aubrey Bloom

December 04, 2025

The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences, and the Texas Advanced Computing...

MD Anderson and HealthEx announce collaboration to develop new platform to give patients direct control of data access

BY Aubrey Bloom

June 09, 2025

The University of Texas MD Anderson Cancer Center and HealthEx today announced a strategic collaboration aimed at developing tools for...

AACR: HER2 targeted therapy shows promise in previously treated lung cancers

April 28, 2025

Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.

These cancers are associated with resistance to standard therapies and a very poor prognosis. As an oral pill, zongertinib would be a more convenient option for patients. Trial data prompted a priority review by the Food and Drug Administration (FDA) earlier this year and sparked a...